Apply the Science Act 2.0

Bill: 117-s-3831
Sponsor: full_name: Sen. Braun, Mike [R-IN]
Introduced: 2022-03-14
Policy area: Health
Subjects: Cardiovascular and respiratory health

Congressional oversight

Emergency medical services and trauma care

Government information and archives

Government studies and investigations

Health promotion and preventive care

Immunology and vaccination

Infectious and parasitic diseases

Medical research

Public contracts and procurement
Latest action: action_date: 2022-03-14
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2022-03-14
action_desc: Introduced in Senate
text: <p><strong>Apply the Science Act 2.0</strong></p> <p>This bill requires the Department of Health and Human Services to seek to contract with the National Academies of Sciences, Engineering, and Medicine to study COVID-19 immunity, including the durability of immunity resulting from an infection, a vaccine, or both.</p>

tv_txt: II 117th CONGRESS 2d Session S. 3831 IN THE SENATE OF THE UNITED STATES March 14, 2022 Mr. Braun (for himself and Mr. Marshall ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To require the National Academies of Sciences, Engineering, and Medicine to conduct a study relating to COVID–19 immunity resulting from a prior infection, vaccination, or both, and the COVID–19 pandemic.

1. Short title This Act may be cited as the Apply the Science Act 2.0 . 2. National Academies of Sciences, Engineering, and Medicine study on natural immunity in relation to the COVID–19 pandemic (a) In general Not later than 45 days after the date of enactment of this Act, the Secretary of Health and Human Services shall seek to enter into a contract with the National Academies of Sciences, Engineering, and Medicine (referred to in this section as the National Academies ) to conduct a study related to the current scientific evidence on the durability of immunity to COVID–19. (b) Inclusions The study pursuant to the contract under subsection (a) shall include— (1) an assessment of scientific evidence related to the durability of immunity resulting from SARS–CoV–2 infection, COVID–19 vaccination, or both, including any differences between population groups; (2) an assessment of the extent to which the Federal Government makes publicly available the scientific evidence used by relevant Federal departments and agencies to inform public health recommendations related to immunity resulting from SARS–CoV–2 infection and COVID–19 vaccination; and (3) a summary of scientific studies and evidence related to SARS–CoV–2 infection-acquired immunity from a sample of other countries or multilateral organizations. (c) Report Not later than 18 months after the date of enactment of this Act, the National Academies shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the study pursuant to subsection (a). (d) Authorization of appropriation There is authorized to be appropriated such sums as may be necessary for fiscal year 2023 to carry out this section.